Literature DB >> 3093793

Rapid and high-yield purification of porcine heart tissue-type plasminogen activator by heparin-sepharose choromatography.

S Soeda, M Kakiki, H Shimeno, A Nagamatsu.   

Abstract

A rapid and high-yield procedure for the purification of single polypeptide tissue-type plasminogen activator (t-PA) from porcine heart tissue has been developed. Delipidated heart tissue was extracted with 0.45 M potassium acetate. The extract was fractionated with ammonium sulfate and purified by a combination of affinity chromatography on heparin-Sepharose CL-6B and gel filtration on Toyopearl HW-55S. The final product had a specific activity of 220,000 IU/mg protein and gave a single protein band (apparent molecular weight; 67,000) in SDS-polyacrylamide gels in the presence or absence of a reducing agent. The increase in specific activity was 3,200-fold, most of which was achieved in the step of heparin-Sepharose chromatography. The yield calculated from the active ammonium sulfate precipitate was about 90% and 500 micrograms or more of the purified enzyme was obtained from 1 kg wet tissue. This procedure may also be useful for the large-scale production of highly purified t-PA from other tissues or tissue culture cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093793     DOI: 10.1016/0024-3205(86)90329-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.

Authors:  P Andrade-Gordon; S Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Secretion of active recombinant human tissue plasminogen activator derivatives in Escherichia coli.

Authors:  J Manosroi; C Tayapiwatana; F Götz; R G Werner; A Manosroi
Journal:  Appl Environ Microbiol       Date:  2001-06       Impact factor: 4.792

3.  Decreased fibrinolytic activity in porcine-to-primate cardiac xenotransplantation.

Authors:  M F Kalady; J H Lawson; R D Sorrell; J L Platt
Journal:  Mol Med       Date:  1998-09       Impact factor: 6.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.